Brexpiprazole Butoxyquinolinone Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Brexpiprazole Butoxyquinolinone Impurity

● In Stock

Catalogue No.:VE007413
CAS No.:N/A
Mol. Formula:C38H41IN4O4S
Mol. Weight:776.73 g/mol

Additional information on Brexpiprazole Butoxyquinolinone Impurity

Parent drug

Brexpiprazole

IUPAC Name

4-(Benzo[b]thiophen-4-yl)-1, 1-bis(4-((2-oxo-1, 2-dihydroquinolin-7-yl)oxy)butyl)piperazin-1-ium iodide

Smiles

O=c7ccc6ccc(OCCCC[N+]5(CCCCOc2ccc1ccc(=O)[nH]c1c2)CCN(c3cccc4sccc34)CC5)cc6[nH]7.I

Synonyms

N/A

Description

It is associate impurity of Brexpiprazole. Brexpiprazole is an atypical antipsychotic. Brexpiprazole is employed to treat schizophrenia and as adjunctive therapy to antidepressant medications for the treatment of major depressive disorder (MDD).

References

Frampton, James E. “Brexpiprazole: A Review in Schizophrenia.” Drugs, vol. 79, no. 2, Jan. 2019, pp. 189–200, https://doi.org/10.1007/s40265-019-1052-5.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url